Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 830,100 | 621,100 | 783,800 | 579,200 | 525,600 |
| Depreciation Amortization | 254,700 | 224,400 | 221,000 | 192,600 | 178,700 |
| Income taxes - deferred | -9,900 | 6,000 | 42,900 | 91,900 | 57,700 |
| Accounts receivable | 183,600 | -16,700 | -109,700 | -34,500 | 51,100 |
| Accounts payable and accrued liabilities | -197,700 | 28,600 | 38,600 | 40,000 | -54,400 |
| Other Working Capital | -140,800 | -168,300 | -288,200 | -92,100 | -29,200 |
| Other Operating Activity | 62,700 | 107,600 | 103,500 | 13,600 | 57,500 |
| Operating Cash Flow | $982,700 | $802,700 | $791,900 | $790,700 | $787,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181,400 | -215,600 | -215,600 | -181,900 | -186,400 |
| Net Acquisitions | -580,900 | -4,936,000 | -30,900 | -1,047,700 | -414,400 |
| Other Investing Activity | 0 | 487,400 | 1,200 | 0 | 0 |
| Investing Cash Flow | $-762,300 | $-4,664,200 | $-245,300 | $-1,229,600 | $-600,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,938,700 | 3,918,000 | 138,800 | 365,200 | 122,500 |
| Debt Issued | 2,939,900 | N/A | N/A | 599,000 | 25,000 |
| Debt Repayment | -148,900 | -400 | -203,600 | -132,600 | -102,100 |
| Common Stock Issued | 62,100 | 72,100 | 77,800 | 96,000 | 135,400 |
| Common Stock Repurchased | -900 | N/A | -326,400 | -207,200 | -271,100 |
| Dividend Paid | -224,000 | -201,600 | -183,500 | -166,900 | -153,400 |
| Other Financing Activity | 165,000 | -4,400 | -18,700 | -38,100 | 24,600 |
| Financing Cash Flow | $-145,500 | $3,783,700 | $-515,600 | $515,400 | $-219,100 |
| Exchange Rate Effect | 14,200 | 6,500 | 29,300 | 12,700 | -400 |
| Beginning Cash Position | 93,600 | 164,900 | 104,600 | 15,400 | 48,700 |
| End Cash Position | 182,700 | 93,600 | 164,900 | 104,600 | 15,400 |
| Net Cash Flow | $89,100 | $-71,300 | $60,300 | $89,200 | $-33,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 982,700 | 802,700 | 791,900 | 790,700 | 787,000 |
| Capital Expenditure | -266,000 | -221,900 | -241,700 | -193,900 | -194,300 |
| Free Cash Flow | 716,700 | 580,800 | 550,200 | 596,800 | 592,700 |